BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21326813)

  • 1. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
    Ren S; Abuel-Haija M; Khurana JS; Zhang X
    Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
    Rabban JT; Chen YY
    Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
    Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
    Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
    Werling RW; Hwang H; Yaziji H; Gown AM
    Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.
    Arnaout-Alkarain A; Kahn HJ; Narod SA; Sun PA; Marks AN
    Mod Pathol; 2007 Feb; 20(2):183-91. PubMed ID: 17206106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial displacement into the lymphovascular space can be seen in breast core needle biopsy specimens.
    Koo JS; Jung WH; Kim H
    Am J Clin Pathol; 2010 May; 133(5):781-7. PubMed ID: 20395526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition.
    Mitchell E; Jindal S; Chan T; Narasimhan J; Sivagnanam S; Gray E; Chang YH; Weinmann S; Schedin P
    Mol Carcinog; 2020 Jul; 59(7):701-712. PubMed ID: 32134153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
    Martinez AP; Cohen C; Hanley KZ; Li XB
    Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast.
    Dabbs DJ; Gown AM
    Diagn Cytopathol; 1999 Apr; 20(4):203-7. PubMed ID: 10204102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters.
    El-Gendi S; Abdel-Hadi M
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
    Hilson JB; Schnitt SJ; Collins LC
    Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
    Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
    Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated podoplanin staining in breast myoepithelial cells: a potential caveat in the diagnosis of lymphatic invasion.
    Yang Z; Adams AL; Hameed O
    Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):425-30. PubMed ID: 19363443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.
    Omi Y; Yamamoto T; Okamoto T; Obara T; Kobayashi M
    Histol Histopathol; 2011 Jan; 26(1):79-86. PubMed ID: 21117029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
    Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
    Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chalkley microvessel but not lymphatic vessel density correlates with axillary lymph node metastasis in primary breast cancers.
    Kanngurn S; Thongsuksai P; Chewatanakornkul S
    Asian Pac J Cancer Prev; 2013; 14(1):583-7. PubMed ID: 23534799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
    Tramm T; Kim JY; Tavassoli FA
    Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
    Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
    Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
    Niu F; Wang L; Zhang W; Lyu S; Niu Y
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.